Atellica CH Urine Albumin (UAlb). Material Number: 11537225

FDA Recall #Z-1484-2026 — Class II — January 20, 2026

Recall #Z-1484-2026 Date: January 20, 2026 Classification: Class II Status: Ongoing

Product Description

Atellica CH Urine Albumin (UAlb). Material Number: 11537225

Reason for Recall

Falsely depressed UAlb patient results may occur. Affected samples with any urine albumin concentration above the UAlb measuring interval >40.0 mg/dL may report values between 6.2 mg/dL and 40.0 mg/dL.

Recalling Firm

Siemens Healthcare Diagnostics, Inc. — Tarrytown, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

4,885 units

Distribution

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Canada, Chile, Curacao,¿St¿Eus, Czech¿Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Korea, Latvia, Malaysia, Netherlands, New Zealand, Norway, Portugal, Romania, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, United¿Kingdom.

Code Information

Material Number: 11537225. UDI-DI: 00630414611099. Lot Numbers: All lot numbers.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated